Seqanswers Leaderboard Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • bruce01
    Senior Member
    • Mar 2011
    • 160

    DESeq2 unknown treatment option?

    Hi all,

    I am wondering how I can include 'unknown' treatment/condition of samples in my design. I have two factors, one is method of mRNA preparation (RiboZero or PolyA), the second is 'responder' or 'non-responder' to a drug that has been administered. There is some missing data here, so about 1/4 of samples are classified 'undetermined response'. At first I thought to include a simple 'unknown' condition, but samples are either responsive to treatment or not. Therefore I thought that classifying a third condition in this way would not make sense. Is there a way to include no information for those samples not designated 'responder'/'non-responder'?

    Thanks, Bruce.
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    The best approach is to simply exclude the unknown responders.

    Comment

    • bruce01
      Senior Member
      • Mar 2011
      • 160

      #3
      I had considered that as the most realistic option, just wondered if there was a way to use unknowns. Thanks for your input.

      Comment

      Latest Articles

      Collapse

      • seqadmin
        Pathogen Surveillance with Advanced Genomic Tools
        by seqadmin




        The COVID-19 pandemic highlighted the need for proactive pathogen surveillance systems. As ongoing threats like avian influenza and newly emerging infections continue to pose risks, researchers are working to improve how quickly and accurately pathogens can be identified and tracked. In a recent SEQanswers webinar, two experts discussed how next-generation sequencing (NGS) and machine learning are shaping efforts to monitor viral variation and trace the origins of infectious...
        03-24-2025, 11:48 AM
      • seqadmin
        New Genomics Tools and Methods Shared at AGBT 2025
        by seqadmin


        This year’s Advances in Genome Biology and Technology (AGBT) General Meeting commemorated the 25th anniversary of the event at its original venue on Marco Island, Florida. While this year’s event didn’t include high-profile musical performances, the industry announcements and cutting-edge research still drew the attention of leading scientists.

        The Headliner
        The biggest announcement was Roche stepping back into the sequencing platform market. In the years since...
        03-03-2025, 01:39 PM
      • seqadmin
        Investigating the Gut Microbiome Through Diet and Spatial Biology
        by seqadmin




        The human gut contains trillions of microorganisms that impact digestion, immune functions, and overall health1. Despite major breakthroughs, we’re only beginning to understand the full extent of the microbiome’s influence on health and disease. Advances in next-generation sequencing and spatial biology have opened new windows into this complex environment, yet many questions remain. This article highlights two recent studies exploring how diet influences microbial...
        02-24-2025, 06:31 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by seqadmin, 03-20-2025, 05:03 AM
      0 responses
      41 views
      0 reactions
      Last Post seqadmin  
      Started by seqadmin, 03-19-2025, 07:27 AM
      0 responses
      46 views
      0 reactions
      Last Post seqadmin  
      Started by seqadmin, 03-18-2025, 12:50 PM
      0 responses
      36 views
      0 reactions
      Last Post seqadmin  
      Started by seqadmin, 03-03-2025, 01:15 PM
      0 responses
      191 views
      0 reactions
      Last Post seqadmin  
      Working...